Pricing Log in Create free account
Friday 6 November 2026 Export PEN’s income statement to Excel — free account

Penumbra, Inc.

PEN Healthcare Medical Devices

Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.

Revenue
+15.6%
EPS
−8.29%
Free cash flow
−37.2%
Total debt
−10.3%

Quarter to September 2026, against a year earlier

319.73 1.38 −0.43%
Market cap
$12.7B
P/E
80.3×
Fwd P/E
68.7×
Dividend yield
—
F-score
8/9
Altman Z
20.17
Beneish M
−2.48
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Penumbra, Inc. (PEN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Penumbra, Inc. (PEN) trades at a EV/Sales of 7.7×. Over the past ten years it has ranged from 0.0× (September 2015) to 18.8× (April 2021); the current reading is higher than 27% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 8.2× 11.24%
FY2024 7.4× (14.08%)
FY2023 8.6× (10.94%)
FY2022 9.7× (29.92%)
FY2021 13.8× 28.66%
FY2020 10.7× 6.06%
FY2019 10.1× 13.52%
FY2018 8.9× 7.73%
FY2017 8.3× 19.69%
FY2016 6.9× 159.40%

Quarterly newest first

Period EV/Sales Change
Sep 2026 7.6× (2.72%)
Jun 2026 7.8× (7.40%)
Mar 2026 8.5× 2.57%
Dec 2025 8.2× 16.40%
43 more quarters

Against its own ten years

Low 0.0× High 18.8×
Ten-year median 9.0×
Current reading's percentile 20

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.6×
BRKR Bruker Corporation compare 3.0×
PODD Insulet Corporation compare 3.5×
GMED Globus Medical, Inc. compare 3.5×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
PEN Penumbra, Inc. 7.7×
TXG 10x Genomics compare 11.5×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PEN